SEER, INC. Interest Expense
SEER, INC. (SEER) reported Interest Expense of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2023-03-06
- SEER, INC. interest expense for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- SEER, INC. interest expense for fiscal 2021 was $22.00K.
- SEER, INC. interest expense for fiscal 2020 was $0.00.
| Period end | Interest Expense 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-06 |
| 2021-12-31 | $22.00K 10-K · filed 2023-03-06 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |